Core Laboratories Inc. Files 8-K on Financials
Ticker: CLB · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1958086
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
CORE LABS dropped an 8-K detailing financials - check it out!
AI Summary
Core Laboratories Inc. /DE/ filed an 8-K on January 29, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing details the company's financial performance and related disclosures.
Why It Matters
This 8-K filing provides crucial updates on Core Laboratories' financial condition and operational results, which can impact investor decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain significant new risks.
Key Players & Entities
- Core Laboratories Inc. /DE/ (company) — Registrant
- January 29, 2025 (date) — Date of Report
- 6316 Windfern Road, Houston, TX 77040 (address) — Principal Executive Offices
- 713-328-2673 (phone_number) — Business Phone
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it covers 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits', but the specific details are within the attached documents.
When was this 8-K filing submitted?
The filing was submitted on January 29, 2025.
What is the primary business of Core Laboratories Inc.?
Core Laboratories Inc. operates in the 'OIL, GAS FIELD SERVICES, NBC' industry, as indicated by its Standard Industrial Classification code.
Where are Core Laboratories Inc.'s principal executive offices located?
The principal executive offices are located at 6316 Windfern Road, Houston, TX 77040.
Has Core Laboratories Inc. undergone any name changes recently?
Yes, the company was formerly known as Core Laboratories Luxembourg S.A., with a date of name change on December 13, 2022.
Filing Stats: 551 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-01-29 16:45:43
Key Financial Figures
- $0.01 — ch registered Common Stock (par value $0.01) CLB New York Stock Exchange Indi
Filing Documents
- clb-20250129.htm (8-K) — 54KB
- clb-ex99_1.htm (EX-99.1) — 843KB
- img77179564_0.jpg (GRAPHIC) — 1257KB
- 0000950170-25-010552.txt ( ) — 2780KB
- clb-20250129.xsd (EX-101.SCH) — 31KB
- clb-20250129_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 29, 2025, Core Laboratories Inc. issued a press release announcing its financial results for the fourth quarter of 2024 and year ending December 31, 2024.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 29, 2025, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on February 10, 2025 and payable March 3, 2025. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued on January 29, 2025 * 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Laboratories Inc. Dated: January 29, 2025 By /s/ Christopher S. Hill Christopher S. Hill Chief Financial Officer